Role of NGAL in Vitiligo

Sohag University

Status: Unknown

Conditions: Vitiligo

Treatments: Diagnostic Test: NGAL

Study type: Interventional

Funder types: Other

Identifiers

NCT05290077

Soh-Med-21-10-20

Details and patient eligibility

About

Role of serum Neutrophil Gelatinase-associated Lipocalin in early detection of cardiovascular risk in patients with Vitiligo

Enrollment: 90 estimated patients

Sex: All

Ages: 20 to 80 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• patients with vitiligo above 20y

Exclusion criteria

• patients with systemic disease Pregnants female Lactating females Patients less than 20 y Patients with active lesions

Trial design

Primary purpose: Screening

Allocation: Non-Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

90 participants in 2 patient groups

Cases

Active Comparator group

Description:

group of vitiligo patients

Treatment:

Diagnostic Test: NGAL

control group

Active Comparator group

Description:

healthy group

Treatment:

Diagnostic Test: NGAL